Related Experiment Videos

Gene therapy for lysosomal storage disorders

N S Yew1, S H Cheng

  • 1Genzyme Corporation, Framingham, MA 01701-9322, USA. nelson.yew@genzyme.com

Current Opinion in Molecular Therapeutics
|August 30, 2001
PubMed

Insights

Gene therapy offers a promising new avenue for treating severe lysosomal storage diseases, especially those affecting the nervous system, with recent advances showing significant potential for these currently untreatable genetic disorders.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Lysosomal storage diseases stem from deficiencies in lysosomal enzymes.
  • Most lysosomal storage diseases lack effective therapeutic options.
  • Neurological manifestations are common and severe in many lysosomal storage diseases.

Purpose of the Study:

  • To review recent advancements in gene therapy for lysosomal storage diseases.
  • To highlight gene therapy as a potential treatment for neurological manifestations.
  • To provide an overview of a large and diverse group of genetic disorders.

Main Methods:

  • Literature review of recent gene therapy research.
  • Analysis of therapeutic strategies for lysosomal storage diseases.
  • Focus on studies addressing neurological aspects.

Main Results:

  • Gene therapy is emerging as a viable treatment approach.
  • Significant progress has been made in developing gene-based therapies.
  • Gene therapy shows particular promise for neurological lysosomal storage diseases.

Conclusions:

  • Gene therapy represents a hopeful frontier for treating lysosomal storage diseases.
  • Further research and development are crucial for clinical application.
  • Gene therapy may offer a transformative treatment for patients with limited options.

Related Concept Videos